Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

31.63
Delayed Data
As of Dec 02
 +0.17 / +0.54%
Today’s Change
28.25
Today|||52-Week Range
37.39
-2.01%
Year-to-Date
Forget Pfizer: Here Are 3 Better Dividend Stocks
Dec 02 / MotleyFool.com - Paid Partner Content
Here's the Best Dividend Stock in Big Pharma
Dec 01 / MotleyFool.com - Paid Partner Content
Merck's Keytruda Gets Priority Review for Hodgkin Lymphoma
Dec 02 / Zacks.com - Paid Partner Content
5 Top Performing S&P 500 Stocks of November
Dec 01 / Zacks.com - Paid Partner Content
Pfizer Offers Positive Phase III Data on Pediatric Epilesy Drug
Dec 02 / Zacks.com - Paid Partner Content
Pfizer's Herceptin Biosimilar Meets Primary Endpoint in Study
Dec 01 / Zacks.com - Paid Partner Content
Why Exelixis Was a Top Stock in 2016 So Far
Dec 02 / MotleyFool.com - Paid Partner Content
What's Pfizer's Excuse for Not Buying Exelixis?
Nov 30 / MotleyFool.com - Paid Partner Content
Pharma Stock Roundup: Nivalis Falls on Study Data, Priority Reviews for Merck's Keytr...
Dec 02 / Zacks.com - Paid Partner Content
ARIAD's Leukemia Drug Iclusig Gets Full Approval in U.S.
Nov 30 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close31.46
Today’s open31.54
Day’s range31.36 - 31.73
Volume19,007,839
Average volume (3 months)23,280,214
Market cap$191.9B
Dividend yield3.79%
Data as of 4:03pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)-21.24%
Earnings growth (this year)+9.95%
Earnings growth (next 5 years)+6.50%
Revenue growth (last year)-1.52%
P/E ratio31.6
Price/Sales4.13
Price/Book3.02

Competitors

 Today’s
change
Today’s
% change
MRKMerck+0.37+0.61%
NVSNovartis+0.42+0.62%
SNYSanofi+0.30+0.76%
ABBVAbbVie+0.27+0.46%
Data as of 4:03pm ET, 12/02/2016

Financials

Next reporting dateJanuary 31, 2017
EPS forecast (this quarter)$0.50
Annual revenue (last year)$48.9B
Annual profit (last year)$7.0B
Net profit margin14.22%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Ian C. Read
Chief Financial Officer &
EVP-Business Operations
Frank A. D'Amelio
Corporate headquarters
New York, New York

Forecasts


Search for Jobs